Stockscreener 앱 받기
2.44
1.24%
0.03
전일 마감가:
$2.41
열려 있는:
$2.45
하루 거래량:
7,104
Relative Volume:
0.14
시가총액:
$7.03M
수익:
$77,900
순이익/손실:
$-8.05M
주가수익비율:
-0.2644
EPS:
-9.2296
순현금흐름:
$-7.47M
1주 성능:
-7.22%
1개월 성능:
+4.72%
6개월 성능:
-28.45%
1년 성능:
-67.77%
1일 변동 폭
$2.43
$2.499
1주일 범위
$2.32
$2.7199
52주 변동 폭
$1.95
$12.03
Aclarion Inc Stock (ACON) Company Profile
명칭
Aclarion Inc
전화
833 275 2266
주소
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, TXG, BTSG, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.44 | 7.47M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
281.93 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
76.50 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
88.76 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
BTSG
Brightspring Health Services Inc
|
57.26 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
97.94 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc 주식(ACON)의 최신 뉴스
ACON: AI-driven NOCISCAN platform accelerates clinical and commercial growth in the global back pain market - TradingView
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites - Orthopedics This Week
Aclarion at Lytham Partners fall investor conference: growth and proof By Investing.com - Investing.com
NYU Langone's spine center serves over 25,000 patients yearly. It joins a back-pain trial. - Stock Titan
Aclarion Inc (ACONW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Aclarion Inc (ACONW) Key Financial Ratios – Valuation, Profitability & More - Value Research
ACON Q2 2026 Earnings: Wider -$1.12 Per-Share Loss Sends Shares Down 4.76%Negative Surprise Momentum - vinanet.vn
Aclarion Inc. (ACON) Slips 4.76% to $2.4 as Key Support Level Comes into FocusShakeout Pattern - careplusvn.com
Aclarion (ACONW) Stock: Holds Near $0.03 in the Latest Reading; Chart View - vinanet.vn
Aclarion (ACON) Outlook: Moves 0.74% Higher to $2.71 on the Day; Price Setup: Traders Can Monitor the $2.57-$2.85 Range in Latest TradingGap Fill Strategy - dars.gov.et
Aclarion (ACON) Upgraded to Buy: Here's Why - Eastern Progress
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACON - TradingView
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - Orthopedics This Week
AclarionAnticipates Having Initial Interna - Moomoo
Aclarion adds University of Arizona to Nociscan spine trial By Investing.com - Investing.com Australia
Aclarion adds University of Arizona to Nociscan spine trial - Investing.com
Aclarion Announces Addition of University of Arizona College of MedicinePhoenix as CLARITY Trial Site - The Manila Times
Aclarion's 300-patient back-pain study now has 10 enrolling sites - Stock Titan
Aclarion (ACON) EPS and Revenue: The Available Earnings Metric Delivers a Miss in Latest Trading; After Results: The Stock Gains 6.54% on the DayROIC Trend Report - vinanet.vn
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com
Top Aclarion Executive Makes Bold Insider Move on Company Stock - TipRanks
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Nigeria
Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayHealthcare Earnings Report - vinanet.vn
ACON | Aclarion, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com
Major Insider Buying Spree Signals Strong Confidence in This Tech Stock - TipRanks
Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Ryan Bond buys $50,059 in ACON shares By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock - Investing.com
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com
Aclarion (ACON) director lifts stake to 23,713 shares - Stock Titan
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et
Aclarion receives patent allowance for MRI scan technology By Investing.com - Investing.com Nigeria
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - The Manila Times
Aclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc Evaluation - Quiver Quantitative
Aclarion receives patent allowance for MRI scan technology - Investing.com
Aclarion Inc. (ACON) Slips 3.39% as Shares Approach Key $2.17 SupportVolume Spike Alerts - careplusvn.com
Aclarion, Inc. Revenue Breakdown – FWB:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – BOATS:ACONW - TradingView
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingView
Aclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock Titan
Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - Bitget
Aclarion Inc. Warrant (ACONW) Slips 2.39% but Remains Supported at $0.02Resistance Breakout Stocks - dars.gov.et
Aclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20Strong Buy Stocks - dars.gov.et
Aclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver Quantitative
Aclarion, Inc Announces Nociscan Now Available At Goodman Campbell Brain & Spine At Ascension St. Vincent - marketscreener.com
Aclarion Inc (ACON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aclarion Inc 주식 (ACON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gould Gregory A | CFO |
Aug 14 '26 |
Buy |
2.45 |
10,000 |
24,500 |
60,000 |
| Bond Ryan | Director |
Aug 13 '26 |
Buy |
2.37 |
21,122 |
50,059 |
76,122 |
| Wesemann William | Director |
Aug 13 '26 |
Buy |
2.34 |
2,150 |
5,031 |
23,713 |
| Neal David K | Director |
Aug 13 '26 |
Buy |
2.40 |
7,500 |
18,000 |
30,002 |
| Ness Brent | Chief Executive Officer |
Aug 13 '26 |
Buy |
2.31 |
5,234 |
12,091 |
111,534 |
| Breidbart Scott | Director |
May 12 '26 |
Buy |
3.18 |
5,664 |
18,012 |
5,664 |
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
0.02%
1.69%
자본화:
|
볼륨(24시간):